Gustavo Murilo Alves

Biochemical Pharmacist from the Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP - USP). He worked with the development of electroanalytical methods, from 2015 to 2017, with the Electroanalytical Group of the Institute of Chemistry of Araraquara of the Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), in the form of a scholarship holder of Junior Scientific Initiation (ICJr) by CNPq. He worked as an intern, with the help of Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), studying the application of SERS in opiate matrices for the study of fentanyl under the guidance of Professor Dr. Bruce Royston McCord at Florida International University, in the first half of 2020. Studied the application of Schiff base-type complexes for the detection of amphetamines, as well as electrochemical methods developed with printed electrodes, also with a FAPESP grant, under the guidance of Professor Dr. Letras da USP (FFCLRP - USP) from July 2019 to September 2020. Internship in the Production sector at Eurofarma Laboratórios, working with quality tools aimed at Lean Manufacturing and improvement implementations in the sectors that involve the production of Parenteral Solutions Large Volume with or without additives. He developed his Course Completion Work under the guidance of Professor Dr. Cristiane Masetto de Gaitani aiming to deepen knowledge about Drug Degradation Products and the legislation on the subject, without assistance. Currently, he works under CLT regime at Eurofarma Laboratórios S/A in the position of Quality Control Analyst, performing various physical-chemical techniques and preparing analysis protocols. It has Green Belt certification and other care for Quality Assurance and optimization of production processes. Recently, it seeks to deepen technical knowledge in people management and regulations that govern good manufacturing practices, production, control and quality assurance of medicines.During the first half of 2022, I was able to act as a focal point for the transfer of technology for the vaccine against COVID-19 between Pfizer and Eurofarma within the scope of physical-chemical quality control, assisted in the preparation of analysis protocols, purchases of consumables, and chemical analysis of the vaccine. (Source: Lattes Curriculum)